Par Drugs & Che.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: INE04LG01015
  • NSEID: PAR
  • BSEID:
INR
89.93
-1.02 (-1.12%)
BSENSE

Feb 02

BSE+NSE Vol: 2158

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2024 is 7.99% vs 2.20% in Dec 2023

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 8.63% vs 36.63% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2024 is 2.03% vs 30.42% in Dec 2023

stock-summary

Interest

YoY Growth in nine months ended Dec 2024 is 0.00% vs -45.45% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023

Compare Nine Monthly Results Of Par Drugs & Che. With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
0
43.47
-43.47
-100.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
0
43.47
-43.47
-100.00%
Raw Material Cost
0
30.97
-30.97
-100.00%
Purchase of Finished goods
0
0.00
0.00
(Increase) / Decrease In Stocks
0
0.00
0.00
Employee Cost
0
4.21
-4.21
-100.00%
Power Cost
0
0.00
0.00
Manufacturing Expenses
0
0.00
0.00
Selling and Distribution Expenses
0
0.00
0.00
Other Expenses
0.00
5.41
-5.41
-100.00%
Total Expenditure (Excl Depreciation)
0
40.59
-40.59
-100.00%
Operating Profit (PBDIT) excl Other Income
0.00
2.88
-2.88
-100.00%
Other Income
0
1.50
-1.50
-100.00%
Operating Profit (PBDIT)
0
4.38
-4.38
-100.00%
Interest
0
0.30
-0.30
-100.00%
Exceptional Items
0
0.00
0.00
Gross Profit (PBDT)
0
4.08
-4.08
-100.00%
Depreciation
0
0.67
-0.67
-100.00%
Profit Before Tax
0
3.41
-3.41
-100.00%
Tax
0
0.95
-0.95
-100.00%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
0
2.46
-2.46
-100.00%
Extraordinary Items
0
0.00
0.00
Prior Period Expenses
0
0.00
0.00
Other Adjustments
0
0.00
0.00
Net Profit
0
2.46
-2.46
-100.00%
Equity Capital
0
10.24
-10.24
-100.00%
Face Value
0
2.00
0.00
Reserves
0
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
0.00%
6.63%
0.00
-6.63%
Gross Profit Margin
0.00%
9.39%
0.00
-9.39%
Public Share Holdings (%)
0%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 78.64 Cr
in Dec 2024

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 7.99% vs 2.20% in Dec 2023

Nine Monthly - Standalone Net Profit
Standalone Net Profit 11.71 Cr
in Dec 2024

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 8.63% vs 36.63% in Dec 2023

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.06 Cr
in Dec 2024

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 2.03% vs 30.42% in Dec 2023

Nine Monthly - Interest
Interest 0.06 Cr
in Dec 2024

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 0.00% vs -45.45% in Dec 2023

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.69%
in Dec 2024

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023